Errata
Year: 2023
Type: article
Abstract: With regard to the article in the February 2022 issue entitled “Blister fluid as a cellular input for ex vivo diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesis” (J Allergy Clin Immunol Global 2022;1:16-21), the ethical/consent statement appeared in the supplemental materials for the article. This statement is also provided in full below:
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,000
OpenAlex ID: W4362635947
